GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $231,000 | +14.9% | 5,249 | -0.3% | 0.01% | 0.0% |
| Q3 2021 | $201,000 | -17.3% | 5,264 | -13.6% | 0.01% | -12.5% |
| Q2 2021 | $243,000 | +15.7% | 6,096 | +3.6% | 0.01% | 0.0% |
| Q1 2021 | $210,000 | -5.0% | 5,884 | -2.1% | 0.01% | -11.1% |
| Q4 2020 | $221,000 | 0.0% | 6,011 | +2.2% | 0.01% | -18.2% |
| Q3 2020 | $221,000 | -9.4% | 5,880 | -1.8% | 0.01% | -15.4% |
| Q2 2020 | $244,000 | +12.4% | 5,985 | +4.5% | 0.01% | -7.1% |
| Q1 2020 | $217,000 | -27.4% | 5,726 | -10.1% | 0.01% | 0.0% |
| Q4 2019 | $299,000 | +12.8% | 6,371 | +2.5% | 0.01% | 0.0% |
| Q3 2019 | $265,000 | +7.7% | 6,217 | +1.0% | 0.01% | +7.7% |
| Q2 2019 | $246,000 | -7.9% | 6,155 | -3.7% | 0.01% | -18.8% |
| Q1 2019 | $267,000 | -1.1% | 6,392 | -9.5% | 0.02% | -11.1% |
| Q4 2018 | $270,000 | -16.7% | 7,065 | -12.3% | 0.02% | -5.3% |
| Q3 2018 | $324,000 | -2.7% | 8,058 | -2.4% | 0.02% | -9.5% |
| Q2 2018 | $333,000 | +4.4% | 8,253 | +1.2% | 0.02% | 0.0% |
| Q1 2018 | $319,000 | -9.1% | 8,157 | -17.6% | 0.02% | -8.7% |
| Q4 2017 | $351,000 | -18.2% | 9,898 | -6.4% | 0.02% | -20.7% |
| Q3 2017 | $429,000 | -12.1% | 10,573 | -6.6% | 0.03% | -17.1% |
| Q2 2017 | $488,000 | +1.0% | 11,321 | -1.3% | 0.04% | -5.4% |
| Q1 2017 | $483,000 | +4.1% | 11,466 | -4.9% | 0.04% | -5.1% |
| Q4 2016 | $464,000 | -18.7% | 12,054 | -9.0% | 0.04% | -22.0% |
| Q3 2016 | $571,000 | -5.9% | 13,247 | -5.4% | 0.05% | -12.3% |
| Q2 2016 | $607,000 | +3.9% | 14,004 | -2.8% | 0.06% | 0.0% |
| Q1 2016 | $584,000 | -5.0% | 14,404 | -5.4% | 0.06% | -9.5% |
| Q4 2015 | $615,000 | +3.7% | 15,232 | -1.2% | 0.06% | -4.5% |
| Q3 2015 | $593,000 | -3.3% | 15,415 | +4.7% | 0.07% | 0.0% |
| Q2 2015 | $613,000 | +5.1% | 14,728 | +16.6% | 0.07% | +6.5% |
| Q1 2015 | $583,000 | +23.8% | 12,627 | +14.7% | 0.06% | +19.2% |
| Q4 2014 | $471,000 | +101.3% | 11,009 | +116.3% | 0.05% | +92.6% |
| Q3 2014 | $234,000 | – | 5,090 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |